
Interreg VI-A IT-AT 2021-2027
Seneca
- Total budget 1.014.504,00 €
- ERDF budget 746.551,72 €
@Credits by SENECAActivities and purpose
The project
Due to the increasing ageing of the population, the prevention and treatment of age-related diseases, such as cancer, are of central importance to health care. The risk of developing cancer increases significantly with age. Cellular ageing processes, known as senescence, play a central role in this process. Senescence also affects the cells of the immune system and leads to a decrease in immune system function and, by weakening cancer defenses, to an increased risk of cancer in old age. The aim of the SENECA project is to decipher the cellular processes of ageing and to search for new therapeutic agents against cancer. The strengths of the SENECA network lie in the complementary and synergistic expertise of the partners involved, who are already working together successfully in joint collaborative projects. By integrating multidisciplinary approaches, combined with targeted training measures for young scientists and comprehensive dissemination strategies, SENECA will make a visible and sustainable contribution to strengthening the research and innovation competence of cross-border regions in the prevention and treatment of age-related diseases.